Peptide record

TPDB42924

αs1-casein f(90_95) Anticancer Antihypertensive Antiviral Neuropeptide modified_plain modified
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB42924
αs1-casein f(90_95)
Anticancer Antihypertensive Antiviral Neuropeptide
Anti-infective peptides Cardiometabolic peptides Cancer-related peptides Neuroactive peptides
AntiCP 2.0 CancerPPD 2.0 Peptipedia SATPdb dbACP iACP-DRLF
modified_plain
Yes
A 6-aa modified multi-activity (Anticancer, Antihypertensive, Antiviral, and other sources) peptide sequence curated from AntiCP 2.0, CancerPPD 2.0, Peptipedia, and other sources, with an available 3D structural model.
C-terminal: Amidation
Sequence
RYLGYL-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
6 reviewed residue count
Amidation Activity
L Activity
Linear Activity
Free Activity
Immunomodulant, Antihypertensive, Antimicrobial,Antiviral, and Antioxidant Activity
Bovine milk Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Inhibition at 12-15g/l
Anticancer

Target

Colon Cancer
AZ-97
Colon

Assay & Model

MTT/MTS assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2013

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.